Cargando…

POS-465 C1Q NEPHROPATHY CAUSING ADVANCED CKD IN THE COVID 19 ERA : A PATIENT WHO RECOVERED TO BASELINE RENAL FUNCTION POST SARS-COV2 AKI ON CKD

Detalles Bibliográficos
Autores principales:	BASHIR, N., Khater, E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854835/ http://dx.doi.org/10.1016/j.ekir.2022.01.495

Ejemplares similares

Infectious consequences of the AKI-to-CKD transition
por: Sánchez Horrillo, Ana, et al.
Publicado: (2022)

Dynamic signature of lymphangiogenesis during AKI and CKD
por: Zarjou, Abolfazl, et al.
Publicado: (2019)

The potential roles of galectin-3 in AKI and CKD
por: Wang, Fengyun, et al.
Publicado: (2023)

The AKI-to-CKD Transition: The Role of Uremic Toxins
por: André, Camille, et al.
Publicado: (2023)

Experimental Aristolochic Acid Nephropathy: A Relevant Model to Study AKI-to-CKD Transition
por: Baudoux, Thomas, et al.
Publicado: (2022)

Meta-analysis of AKI to CKD transition in perioperative patients
por: M. Abdala, Pedro, et al.
Publicado: (2021)

Epigenetic memory contributing to the pathogenesis of AKI-to-CKD transition
por: Tanemoto, Fumiaki, et al.
Publicado: (2022)

From AKI to CKD: Maladaptive Repair and the Underlying Mechanisms
por: Wang, Zhiwen, et al.
Publicado: (2022)

Depletion of macrophages with clodronate liposomes partially attenuates renal fibrosis on AKI–CKD transition
por: Hu, Zhizhi, et al.
Publicado: (2023)

The COVID-19 nephrology compendium: AKI, CKD, ESKD and transplantation
por: Kant, Sam, et al.
Publicado: (2020)

IL-18 deficiency ameliorates the progression from AKI to CKD
por: Luan, Junjun, et al.
Publicado: (2022)

REST contributes to AKI-to-CKD transition through inducing ferroptosis in renal tubular epithelial cells
por: Gong, Shuiqin, et al.
Publicado: (2023)

RIPK3-MLKL-mediated necroinflammation contributes to AKI progression to CKD
por: Chen, Hui, et al.
Publicado: (2018)

EGFR drives the progression of AKI to CKD through HIPK2 overexpression
por: Xu, Luyang, et al.
Publicado: (2019)

The Road from AKI to CKD: Molecular Mechanisms and Therapeutic Targets of Ferroptosis
por: Guo, Runzhi, et al.
Publicado: (2023)

HDAC3 aberration-incurred GPX4 suppression drives renal ferroptosis and AKI-CKD progression
por: Zhang, Lijun, et al.
Publicado: (2023)

The critical role of FXR is associated with the regulation of autophagy and apoptosis in the progression of AKI to CKD
por: Kim, Dong-Hyun, et al.
Publicado: (2021)

Uremic Toxins and Protein-Bound Therapeutics in AKI and CKD: Up-to-Date Evidence
por: Chen, Jia-Huang, et al.
Publicado: (2021)

DAPA-CKD: The Beginning of a New Era in Renal Protection
por: Cherney, David Z.I., et al.
Publicado: (2021)

Rituximab in Primary Membranous Nephropathy With Severe CKD
por: Naik, Sachin, et al.
Publicado: (2023)

Recombinant Long-Acting Thioredoxin Ameliorates AKI to CKD Transition via Modulating Renal Oxidative Stress and Inflammation
por: Nishida, Kento, et al.
Publicado: (2021)

AKI-to-CKD transition is a potential mechanism for non-albuminuric diabetic kidney disease
por: Lee, Kyung, et al.
Publicado: (2022)

A potential link between fibroblast growth factor-23 and the progression of AKI to CKD
por: Lu, Yinghui, et al.
Publicado: (2023)

Altered gut microbiome plays an important role in AKI to CKD transition in aged mice
por: Kim, Myung-Gyu, et al.
Publicado: (2023)

Activation of EP4 alleviates AKI-to-CKD transition through inducing CPT2-mediated lipophagy in renal macrophages
por: Guan, Xu, et al.
Publicado: (2022)

Urinary peptidome analysis in CKD and IgA nephropathy
por: Li, Zewen, et al.
Publicado: (2023)

Comparison of the treatment efficacy of umbilical mesenchymal stem cell transplantation via renal subcapsular and parenchymal routes in AKI-CKD mice
por: Huang, Mengjie, et al.
Publicado: (2022)

POS-694 RENAL TRANSOLANTATION STRUGGLES DURING COVID-19 ERA: DRUG/DRUG INTERACTION MAY LEAD TO GRAFT LOSS
por: BASHIR, N., et al.
Publicado: (2021)

POS-290 MORTALITY IN COVID-19 PATIENTS WITH CKD WITH AND WITHOUT KIDNEY REPLACEMENT THERAPY IN WESTERN MEXICO
por: GARCIA RIVERA, A., et al.
Publicado: (2022)

Masked CKD in hyperthyroidism and reversible CKD status in hypothyroidism
por: Uchiyama-Matsuoka, Natsumi, et al.
Publicado: (2022)

The VEGF Inhibitor Soluble Fms-like Tyrosine Kinase 1 Does Not Promote AKI-to-CKD Transition
por: van Aanhold, Cleo C. L., et al.
Publicado: (2022)

Roles of interferon regulatory factor 4 in the AKI-CKD transition, glomerular diseases and kidney allograft rejection
por: Song, Jianling, et al.
Publicado: (2023)

Benchmarking CKD: incidence of CKD in a European country with low prevalence of CKD and kidney replacement therapy
por: Ortiz, Alberto
Publicado: (2022)

Effect of febuxostat on renal function in patients from South China with CKD3 diabetic nephropathy
por: Wen, Huang, et al.
Publicado: (2020)

Flavin containing monooxygenase 2 regulates renal tubular cell fibrosis and paracrine secretion via SMURF2 in AKI-CKD transformation
por: Wang, Longfei, et al.
Publicado: (2023)

Constipation in CKD
por: Sumida, Keiichi, et al.
Publicado: (2019)

Diabetic Nephropathy and CKD—Analysis of Individual Patient Serum Creatinine Trajectories: A Forgotten Diagnostic Methodology for Diabetic CKD Prognostication and Prediction
por: Onuigbo, Macaulay Amechi Chukwukadibia, et al.
Publicado: (2015)

Genetic polymorphism in C3 is associated with progression in chronic kidney disease (CKD) patients with IgA nephropathy but not in other causes of CKD
por: Ibrahim, Sara T., et al.
Publicado: (2020)

CKD Awareness in the General Population: Performance of CKD-Specific Questions
por: Tuot, Delphine S., et al.
Publicado: (2019)

Renal Hypoxia in CKD; Pathophysiology and Detecting Methods
por: Hirakawa, Yosuke, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_tsaea9g3v46h24i5f9hc85n909